[Effect of clonidine on oro-cecal transit time in normal man]. 1989

P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
Service de Gastroentérologie, Hôpital Rothschild, Paris.

The aim of our study was to explore the effect of clonidine on the mouth to caecum transit time in healthy man. Hydrogen-breath test, using lactulose 10 g, was carried out in 10 healthy male volunteers, in double-blind conditions and in random sequences of medications, placebo or clonidine (0.3 mg per os). Clonidine increased the mouth to caecum transit time significantly (p = 0.013): from 85 +/- 12 min. (with placebo) to 139 +/- 16 min. (mean +/- SE). This study suggests that the antidiarrheal action of clonidine is due, at least in part, to effect on motility of the proximal gut.

UI MeSH Term Description Entries
D007792 Lactulose A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887) Amivalex,Duphalac,Normase
D008297 Male Males
D010528 Peristalsis A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction. Peristalses
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004947 Esophagus The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
D005772 Gastrointestinal Transit Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function. GI Transit,GI Transits,Gastrointestinal Transits,Transit, GI,Transit, Gastrointestinal,Transits, GI,Transits, Gastrointestinal

Related Publications

P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
August 1995, Aging (Milan, Italy),
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
January 1990, European journal of clinical pharmacology,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
June 2004, European journal of clinical investigation,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
February 2013, Pharmaceutical research,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
October 2006, European journal of clinical investigation,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
January 1999, European journal of clinical pharmacology,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
October 1989, Zeitschrift fur Gastroenterologie,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
January 1998, Hepato-gastroenterology,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
December 2004, Gastroenterologie clinique et biologique,
P Baumer, and T Danays, and L Lion, and J Cosnes, and J P Gendre, and Y Le Quintrec
August 1995, Revista medica de Chile,
Copied contents to your clipboard!